[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Novartis AG (NVS)

Novartis AG receives FDA approval for Itvisma, a gene replacement therapy for spinal muscular atrophy. The company is also reportedly in advanced discussions to acquire Avacta Group's ADC assets.

About Novartis AG

Novartis AG is a global pharmaceutical company focused on developing and manufacturing innovative medicines.
Novartis AG uses the ticker $NVS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Novartis AG (NVS) trading volume is up XXXXX% from the previous week.
Novartis AG (NVS) social dominance is up XXXXXX% from the previous week.
Novartis AG (NVS) Galaxy Score™ is up XXXXX% from the previous week.
Novartis AG (NVS) posts created is up XXXXX% from the previous week.
Novartis AG Price hit a 52-Week high of $XXXXXX for the hour
Novartis AG Price hit an all time of $XXXXXX for the hour

Price: $XXXXXX

Price 24-Hour Time-Series Raw Data
The stock price is experiencing downward pressure, likely due to Q3 earnings that missed expectations, despite the positive news of the Avidity Biosciences acquisition. The market may be weighing the substantial investment against current financial performance.

24-Hour: XXXX% 7-Day: -XXXX% 30-Day: XXXX%

1-Year High: $XXXXXX on 2025-12-03
1-Year Low: $XXXXX on 2024-12-19

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novartis AG (NVS) is currently AltRank #418 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX +193
X Month: XXX -XX
X Months: XXX +16
X Year: XXX -XX
1-Year High: XXXXX on 2025-02-18
1-Year Low: XX on 2025-11-21

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +6
X Month: XX -XX
X Months: XX +7
X Year: XX -XX
1-Year High: XX on 2025-05-20
1-Year Low: XX on 2025-01-09

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX -XX%
X Month: XXXXXXXXXX +90%
X Months: XXXXXXXXXX +168%
X Year: XXXXXXXXXX +172%
1-Year High: XXXXXXXXX on 2025-11-27
1-Year Low: XXXXXX on 2025-01-07

Engagements by network (24h): News: XXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +34%
X Year: XXXXXX +196%
1-Year High: XXXXX on 2025-10-27
1-Year Low: XXX on 2024-12-25

Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX -XXXX%
X Months: XXXXX +28%
X Year: XXXXXX +191%
1-Year High: XXX on 2025-10-27
1-Year Low: XXX on 2024-12-25

The most influential creators that mention Novartis AG in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@stats_feed	X	XXXXXXXXX	X	XXXXX
@RNAiAnalyst	X	XXXXXX	X	XXXXX
@Darwin_Knows	X	XXX	XX	XXXXX
@ValueSense_io	X	XXXXXX	X	XXXXX
@Regenbo5en	X	XXXXX	X	XXX
@grok	X	XXXXXXXXX	XX	XXX
@diariomedico	X	XXXXXXX	X	XXX
@GlobalStatsX	X	XXXXXX	X	XXX
@robertfsiegmund	X	XXX	X	XXX
@novartis	XX	XXXXXX	XX	XXX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% +6%
X Months: XX% +4%
X Year: XX% -X%
1-Year High: XX% on 2025-10-26
1-Year Low: XX% on 2025-11-26

Most Supportive Themes:

Acquisition of Avidity Biosciences: (70%) Novartis AG is acquiring Avidity Biosciences for $XX billion, strengthening its neuroscience pipeline.
Pipeline Advancements: (10%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.

Most Critical Themes:

Drug Pricing and Access Concerns: (60%) There are discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.044%
X Month: XXXXX% +0.033%
X Months: XXXXX% +0.034%
X Year: XXXXX% +0.038%
1-Year High: XXXX% on 2025-04-12
1-Year Low: XXXXX% on 2025-07-01

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXX% on 2024-12-16

Market Cap: $XXXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$0.17%
X Month: $XXXXXXXXXXXXXXX +$1.60%
X Months: $XXXXXXXXXXXXXXX +$7.80%
X Year: $XXXXXXXXXXXXXXX +$28%
1-Year High: $XXXXXXXXXXXXXXX on 2025-12-03
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19

Top Novartis AG News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"Mirum Therapeutics to buy Bluejay Therapeutics for up to $820M - San Francisco Business Times"
News Link @bizjournals 2025-12-10T01:05Z 228.6M followers, XXX engagements

"Notable analyst calls this week: Novartis Albemarle and Zscaler among top picks Seeking Alpha"
News Link @SeekingAlpha 2025-12-06T17:30Z 228.6M followers, 1910 engagements

"Novartis receives FDA approval for Itvisma the only gene replacement therapy for children two years and older teens and adults with spinal muscular atrophy (SMA)"
News Link @PRNewswire 2025-11-25T12:28Z 228.6M followers, 1483 engagements